Antisense Therapeutics ^Public

Antisense Therapeutics is a biopharmaceutical drug discovery and development company focused on creating and commercializing novel antisense therapeutics. Their main goal is to develop innovative therapies for rare diseases with high unmet medical need. They are currently working on drug candidates for Duchenne Muscular Dystrophy (DMD), Multiple Sclerosis (MS), and Acromegaly. Their achievements include advancing the field of antisense therapeutics and providing potential treatment options for patients with limited options.